Cosmos Health Inc.

Name: Cosmos Health Inc. standardized financial statements, quarterly
Creator: Listed

COSMNasdaqCIK 1474167Consumer discretionaryFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$19.0m, Q2 FY2026

Operating income−$2.9m, Q2 FY2026

Net income−$6.1m, Q2 FY2026

Cosmos Health Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	12.8	15.8	14.6	13.2	12.4	14.2	13.7	14.7	17.1	19.7	17.9	19.0
Cost of revenue	$m	11.6	14.6	13.3	12.4	11.2	13.2	11.7	13.6	14.5	17.6	16.5	17.5
Gross profit	$m	1.2	1.2	1.3	0.8	1.2	1.0	2.0	1.2	2.6	2.1	1.4	1.5
Research and development	$m	not reported	not reported	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.1
Operating income	$m	(3.0)	(13.6)	(1.8)	(2.5)	(2.2)	(9.0)	(0.8)	(2.6)	(1.8)	(11.4)	(2.2)	(2.9)
Interest expense	$m	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.4	0.7	0.7	0.4	0.6
Income tax	$m	(0.1)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$m	(3.3)	(13.8)	(1.9)	(2.6)	(8.4)	(3.3)	(0.8)	(2.8)	(5.4)	(10.1)	(2.8)	(6.1)
Diluted EPS	$ per share	(0.27)	not reported	(0.11)	(0.15)	(0.45)	not reported	(0.03)	(0.10)	(0.17)	not reported	(0.06)	(0.10)
Basic EPS	$ per share	(0.27)	not reported	(0.11)	(0.15)	(0.45)	not reported	(0.03)	(0.10)	(0.17)	not reported	(0.06)	(0.10)

Balance sheet

Cash and equivalents$1.8m, Q2 FY2026

Long-term debt$3.2m, Q2 FY2026

Shareholders' equity$20.7m, Q2 FY2026

Cosmos Health Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	not reported	not reported	not reported	not reported	not reported	0.3	not reported	0.7	0.9	0.7	0.5	1.8
Current assets	$m	46.5	36.6	34.3	33.4	36.2	25.5	27.8	30.6	38.1	38.4	36.9	36.7
Total assets	$m	71.5	66.0	62.3	60.8	64.5	54.3	57.2	61.8	69.5	65.5	62.4	61.5
Current liabilities	$m	22.6	24.3	23.6	24.8	25.2	25.8	26.6	31.2	38.5	38.3	34.1	34.8
Total liabilities	$m	27.0	30.0	27.8	28.7	29.5	29.8	31.2	35.6	46.4	47.1	42.5	40.8
Long-term debt	$m	4.2	1.3	1.2	3.9	4.3	4.1	4.9	5.2	5.4	3.8	3.5	3.2
Current portion of debt	$m	not reported	1.9	1.6	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	44.2	36.0	34.5	32.1	35.0	24.5	26.0	26.2	23.1	18.4	19.8	20.7

Cash flow

Operating cash flow−$1.7m, Q2 FY2026

Capital expenditure$63.6k, Q2 FY2026

Share repurchases$0, Q4 FY2024

Cosmos Health Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(4,524)	952	(3,412)	(1,211)	740	(3,834)	(186)	(1,210)	(2,455)	(4,596)	(1,067)	(1,718)
Capital expenditure	$k	16.6	46.7	82.7	34.2	229	72.5	12.5	22.5	12.7	7.9	11.4	63.6
Share repurchases	$k	not reported	0.2	not reported	not reported	not reported	0.0	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)59.92m, Q2 FY2026

Cosmos Health Inc., shares, quarterly
Line item	Unit	Q2 FY20222022-06-30	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	19.5	25.8	10.6	12.6	16.9	17.8	18.4	26.0	28.8	30.6	47.1	59.9

Shares outstanding: 100.63m at Aug 18, 2026, from the cover of the 10-Q filed Aug 18, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.